sixteen nonobese patients with radiolucent gallstones were randomly allocated into two treatment groups receiving 15 mg/kg/day ursodeoxycholic acid ( group a ) or 15 mg/kg/day lactose ( group b ) administered three times daily for 30 days .
C0008350
gallstones
C0042105
ursodeoxycholic acid